PLP1 and myeloid sarcoma: Given the high specificity of our assay, as evidenced by the absence of PLP1 complex Abs in more than 80 combined inflammatory and non-MS control CSF samples, the detection of conformational immunoreactivity to PLP1 membrane complexes in CSF or serum may provide a new diagnostic tool for MS.